PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 18, 2009New England Journal of Medicine2,931 citationsOpen Access

Mortality Results from a Randomized Prostate-Cancer Screening Trial

View Full Paper
GAGerald L. AndrioleECE. David CrawfordRGRobert L. Grubb

Key Points

  • To evaluate mortality rates from prostate cancer after screening over a follow-up period of 7 to 10 years.
  • Randomized trial design with two study groups.
  • Follow-up duration of 7 to 10 years.
  • ClinicalTrials.gov identifier NCT00002540.
  • Rate of death from prostate cancer was very low in both groups.
  • No significant difference in mortality rates between the study groups.

Abstract

After 7 to 10 years of follow-up, the rate of death from prostate cancer was very low and did not differ significantly between the two study groups. (ClinicalTrials.gov number, NCT00002540.)

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Andriole et al. (2009) studied this question.

synapsesocial.com/papers/69de79381d9bba5129b0c154https://doi.org/10.1056/nejmoa0810696
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality2007 · 520 citations
  2. 2AJCC Cancer Staging Manual2016 · 17,438 citations
  3. 3Screening decreases prostate cancer mortality: 11‐year follow‐up of the 1988 Quebec prospective randomized controlled trial2004 · 226 citations
  4. 4Infection after transrectal core biopsies of the prostate1996 · 149 citations
  5. 5Death review process in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial2000 · 89 citations